Repros Therapeutics Inc. (RPRX) Announces Formation of Androxal® Clinical and Commercial Advisory Board
7/10/2013 9:16:43 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
THE WOODLANDS, Texas, July 9, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced the formation of an international, multi-disciplinary, clinical advisory board to help maximize the commercial opportunity for Androxal.
Help employers find you! Check out all the jobs and post your resume.
comments powered by